[March 27, 2017] |
 |
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Natus Medical Incorporated and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP (the "Firm") announces a class action lawsuit against
Natus Medical Incorporated ("Natus or the "Company") (Nasdaq: BABY).
Investors who purchased or otherwise acquired shares between October 16,
2015 and April 3, 2016, inclusive (the "Class Period") are encouraged to
contact the Firm in advance of the March 31, 2017 lead plaintiff
motion deadline.
If you purchased shares of Natus during the Class Period, please contact
Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd
Floor, Irvine, CA (News - Alert) 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until certification
occurs, you are not represented by an attorney. You may choose to tke
no action and remain a passive class member.
According to the Complaint, Natus made materially false and/or
misleading statements, and/or failed to disclose that: the Venezuelan
government failed to make tens of millions of dollars in prepayments to
Natus, which were required to have been paid beginning in October 2015;
that Natus had no means to effectively enforce its rights under its
supply contract, as Venezuela was the exclusive forum for dispute
resolution; that the Company's receipt of revenues pursuant to the
supply contract was contingent on the outcome of Venezuelan elections;
and that as a result of the above, Natus was not going to achieve the
increased guidance provided by the Company which lacked a reasonable
basis. When this information reached the public, shares of Natus fell in
value.
If you wish to learn more about this lawsuit, or if you have questions
concerning this notice or your rights, please contact Joon M. Khang, a
prominent litigator for almost two decades, by telephone: (949)
419-3834, or via e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170327006243/en/
[ Back To TMCnet.com's Homepage ]
|